• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Federated learning for COVID-19 mortality prediction in a multicentric sample of 21 hospitals

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2025 Nov 24;21(11):e1013695.
doi: 10.1371/journal.pcbi.1013695. eCollection 2025 Nov. Federated learning for COVID-19 mortality prediction in a multicentric sample of 21 hospitals

Roberta Moreira Wichmann[SUP] 1 [/SUP], Murilo Afonso Robiati Bigoto[SUP] 2 [/SUP], Alexandre Dias Porto Chiavegatto Filho[SUP] 2 [/SUP]



Affiliations
Abstract

We evaluated Federated Learning (FL) strategies for predicting COVID-19 mortality using a multicenter sample of 17,022 patients from 21 diverse Brazilian hospitals. We tested horizontal FL architectures employing Logistic Regression (LR) and a Multi-Layer Perceptron (MLP) via parameter aggregation, alongside a novel Federated Random Forest (RF) using ensemble aggregation. Performance gain (ΔAUC, calculated as AUC[Formula: see text] minus AUC[Formula: see text]) was quantified using bootstrap analysis to determine 95% confidence intervals. FL models demonstrated a beneficial collaborative effect. The average ΔAUC across the network was +0.0018 for LR, +0.0599 for MLP, and +0.0528 for RF. Crucially, the gain's magnitude and statistical significance showed a strong inverse correlation with local patient volume (N). Substantial and statistically significant gains concentrated in data-limited institutions (N < 500). For example, the smallest hospital (N=86) achieved a remarkable ΔAUC of 0.3682 (95% CI [0.0908, 0.6307]) with the RF model. However, interpreting these benefits requires caution because the 95% CIs for ΔAUC crossed zero for the majority of hospitals, suggesting the collaborative model's statistical advantage is not universally certain at every site. This trade-off was particularly evident with the MLP model which, despite achieving the highest average ΔAUC, was the most volatile algorithm, registering the maximum performance degradation in the network (ΔAUC = -0.0884, 95% CI [-0.1527, -0.0273]) due to its high sensitivity to local data distribution disparities (non-IID). This study validates FL as an equity-enabling mechanism that effectively enhances predictive capacity where local data scarcity is highest. Our findings underscore that maximizing the most statistically certain benefits of FL requires continuous monitoring and local validation for successful clinical deployment across diverse settings.


 
Back
Top Bottom